AKBA Stock Recent News
AKBA LATEST HEADLINES
Check these penny stocks out for your watchlist The post Hot Penny Stocks to Buy Now? 3 to Watch in Early July appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
Tips for making a list of trending penny stocks in 2022 The post How to Find Trending Penny Stocks in 2022 appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
Akebia Therapeutics (AKBA) stock is taking off on Friday after the kidney treatment company revealed the return of rights for vadadustat. The post Why Is Akebia Therapeutics (AKBA) Stock Up 14% Today?
Penny stocks under $1 to watch. The post Best Penny Stocks To Buy Right Now?
Gainers Quoin Pharmaceuticals, Ltd. (NASDAQ: QNRX) rose 83.2% to $0.8250 in pre-market trading after dropping 10% on Thursday.
Some of the stocks that may grab investor focus today are: Micron Technology Inc (NASDAQ: MU) reported upbeat financial results for its third quarter, but issued weak guidance for its fourth quarter. Micron shares dropped 1.4% to $54.50 in the after-hours trading session.
Akebia Therapeutics Inc (NASDAQ: AKBA) shares are surging in Thursday's after-hours session after the company executed an agreement to terminate its Vadadustat collaboration and license agreements with Otsuka Pharmaceutical. As a result of the termination of the agreements, Akebia.
AKBA stock is up big, but the lack of news is concerning considering that Akebia Therapeutics already faces a regulatory setback. The post Akebia Therapeutics (AKBA) Stock Soars 18% Despite Lack of News appeared first on InvestorPlace.
Here's what you need to know about trading penny stocks today The post What to Know About Trading Penny Stocks on June 13th appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
CAMBRIDGE, Mass. , June 3, 2022 /PRNewswire/ -- Akebia Therapeutics, Inc. (Nasdaq: AKBA), a biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease, today announced that John Butler, Chief Executive Officer, will present at the Jefferies Healthcare Conference on Thursday, June 9, 2022 at 10:30 a.m.